Trials / Completed
CompletedNCT00235183
Plasma Transfusion in Liver Transplantation
Plasma Transfusion in Liver Transplantation : a Randomized, Double Blind, Multicenter Trial of Methylene Blue, Solvent/Detergent and Quarantined Plasma.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Etablissement Français du Sang · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare the clinical efficacy of three types of plasma secured on the viral level either by quarantine or by chemical treatment in patients undergoing liver transplantation.
Detailed description
Three types of plasma are transfused in bleeding patients undergoing liver transplantation: * quarantined plasma, * methylene blue treated plasma, * solvent/detergent plasma. The main purpose is to show that the volume of methylene blue treated plasma consumed intraoperatively is equivalent to that of the 2 other types of plasma. In addition, the correction of coagulation abnormalities are studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | plasma | transfusion of more than 15 mL/Kg of plasma |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2009-12-01
- Completion
- 2010-12-01
- First posted
- 2005-10-10
- Last updated
- 2014-02-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00235183. Inclusion in this directory is not an endorsement.